Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2014; 20(40): 14895-14903
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14895
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14895
Figure 4 Oridonin regulates the expression of proteins in the transforming growth factor β/Smad pathway.
Western blot analysis of the effect of oridonin on proteins in the Smad signaling pathway in BxPC-3 cells. The BxPC-3 cells were treated with 0, 8, 16, or 32 μg/mL oridonin for 24 h. Three independent experiments were performed, and a representative result is shown. TGFβ1: Transforming growth factor β1; BMP-2: Bone morphogenetic proteins 2; Smads: Sma and mad homologues.
- Citation: Chen RY, Xu B, Chen SF, Chen SS, Zhang T, Ren J, Xu J. Effect of oridonin-mediated hallmark changes on inflammatory pathways in human pancreatic cancer (BxPC-3) cells. World J Gastroenterol 2014; 20(40): 14895-14903
- URL: https://www.wjgnet.com/1007-9327/full/v20/i40/14895.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i40.14895